The author views CYPH as a potentially higher-beta, cash/spot way to gain leveraged exposure to ZEC, without the liquidation risk of perpetuals, but warns that digital-asset treasuries carry additional risks. They say they own CYPH alongside spot ZEC; the quoted commentary suggests a possible retest and further upside, but gives no price target or timeframe.